SCHEMBL14188482

SCHEMBL14188482

O=C1NCCn2nc(-c3ccnc(-c4ccc(F)cc4Cl)n3)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.46
PIM1 P11309 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
NISCH Q9Y2I1 1/20 0.38
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
DPP4 P27487 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
CNR2 P34972 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPK14 Q16539 3/20 0.34
MAPKAPK2 P49137 2/20 0.34
PARP1 P09874 2/20 0.34
MAPK13 O15264 2/20 0.34
MAPK12 P53778 2/20 0.34
MAPK11 Q15759 2/20 0.34
LRRK2 Q5S007 1/20 0.34
PARP10 Q53GL7 1/20 0.32
ROS1 P08922 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14188671 0.92 CDC7 (0.46) CDC7PIM1PIM2ALDH1A1MAPKAPK2
SCHEMBL4996436 0.89 CDC7 (0.48) CDC7PIM1PIM2DPP4DPP7
SCHEMBL4993638 0.89 CDC7 (0.48) CDC7PIM1PIM2NPC1RAB9A
SCHEMBL14188672 0.87 CDC7 (0.46) CDC7PIM1PIM2NPC1RAB9A
SCHEMBL14188480 0.87 CDC7 (0.46) CDC7PIM1PIM2DPP4DPP7
SCHEMBL14188544 0.87 CDC7 (0.46) CDC7PIM1PIM2PARP1LRRK2
SCHEMBL14188525 0.87 CDC7 (0.46) CDC7PIM1PIM2NPC1RAB9A
SCHEMBL14188687 0.87 CDC7 (0.46) CDC7PIM1PIM2CNR2MAPK14
SCHEMBL14188615 0.87 CDC7 (0.46) CDC7PIM1PIM2MAPKAPK2PARP1
SCHEMBL5002969 0.87 CDC7 (0.48) CDC7PIM1PIM2ALDH1A1MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS MKNK2, MAPKAPK2, MAP3K2 CDC7 487/4885PIM1 539/4885PIM2 309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.